Graft vs Host Disease: all 815 studies
Page 1 of 9. Open to participants first (138), then studies with results posted, then the rest; newest registration first within each.
- Nutritional Intervention for Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07850375Not applicable
- Use of Bone Marrow Stem Cells (MesenCell) for the Treatment of Patients With Chronic Graft-versus-host DiseaseNot yet recruitingNCT07826676Phase 1
- CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell TransplantationNot yet recruitingNCT07808112Phase 2
- Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNINot yet recruitingNCT07796620Phase 1/2
- Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic ChildrenRecruitingNCT07725263
- Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant PatientsRecruitingNCT07724873Phase 1/2
- Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.RecruitingNCT07708987Phase 2
- Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCTRecruitingNCT07689630Phase 3
- Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCTNot yet recruitingNCT07675174Phase 1/2
- Evaluating the Effects of Propionate and Butyrate Supplementation on the Intestinal Health of Healthy VolunteersNot yet recruitingNCT07611370Phase 1
- A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCTRecruitingNCT07606703Phase 2
- FMT for Pediatric SR-aGVHDRecruitingNCT07602751Phase 1/2
- A Study of Ruxolitinib in Patients With Graft-Versus Host DiseaseRecruitingNCT07594587
- CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)Not yet recruitingNCT07576699Phase 1/2
- Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT07572669Phase 2
- Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female DonorsRecruitingNCT07570745Phase 2
- Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.RecruitingNCT07569653Phase 4
- A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host DiseaseNot yet recruitingNCT07568535Phase 3
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingNCT07566377Phase 2
- Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic MalignanciesRecruitingNCT07565220Phase 1
- Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)RecruitingNCT07509749Phase 2
- Fatigue and Cognitive Dysfunction Due to Synaptopathy or Graft Versus Host (GVH) Disease in the Brain.RecruitingNCT07365696
- Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHDRecruitingNCT07364617Phase 2
- A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantRecruitingNCT07359859Phase 2
- Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell LymphomaRecruitingNCT07356245Phase 2
- A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in ChildrenRecruitingNCT07350057Phase 1
- Psychiatric Status and Symptom Severity in Graft-versus-Host Disease (GvHD).RecruitingNCT07314892
- Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALLRecruitingNCT07297914Phase 2/3
- BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell TransplantationRecruitingNCT07246031Phase 2
- Emerging Indications for Hyperbaric Oxygen TreatmentNot yet recruitingNCT07240649Phase 4
- Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched DonorRecruitingNCT07238712Phase 2
- Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell TransplantationRecruitingNCT07235501
- Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeRecruitingNCT07216443Phase 2
- HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCRNot yet recruitingNCT07210242
- Vitamin C With Steroids for Gastrointestinal GVHDNot yet recruitingNCT07197749Early Phase 1
- Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological MalignanciesNot yet recruitingNCT07193420Phase 3
- Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHDRecruitingNCT07184853Not applicable
- Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.Enrolling by invitationNCT07162688Phase 1/2
- A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)RecruitingNCT07118254Phase 2
- Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host DiseaseRecruitingNCT07029958Phase 4
- Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.RecruitingNCT07028112
- Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior TherapyRecruitingNCT07012304Phase 1/2
- A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell TransplantRecruitingNCT07006506Phase 2
- Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantRecruitingNCT06996119Phase 1
- Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHDRecruitingNCT06991361Phase 1
- A Study of Stem Cells Lenses in the coGVHD SubjectsNot yet recruitingNCT06952114Early Phase 1
- A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell TransplantationNot yet recruitingNCT06949267Early Phase 1
- A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHDNot yet recruitingNCT06941350Phase 1/2
- Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD PreventionRecruitingNCT06926595Phase 2
- Multidisciplinary Intervention for Adults With Chronic Graft-versus-host DiseaseRecruitingNCT06910969Not applicable
- Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional TreatmentsNot yet recruitingNCT06905834Phase 2
- Efficacy of Human Chorionic Gonadotropin in Acute GVHD TreatmentRecruitingNCT06904599Phase 2
- The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCTEnrolling by invitationNCT06864598
- Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host DiseaseRecruitingNCT06824103Phase 4
- Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningRecruitingNCT06815003Phase 2
- Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell TransplantationRecruitingNCT06799195Phase 2
- Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher SeverityRecruitingNCT06756061Phase 2
- Universal CNK-UT Therapy for Refractory aGVHDRecruitingNCT06750133Phase 1
- Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT06715046
- Tissue-resident Immune Cell Subsets in aGVHDRecruitingNCT06708507
- Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell TransplantationRecruitingNCT06705062Phase 3
- Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHDEnrolling by invitationNCT06698211
- Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host DiseaseRecruitingNCT06682169Phase 3
- A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) TreatmentNot yet recruitingNCT06677255Phase 1/2
- Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent ThalassemiaRecruitingNCT06657391Phase 2
- Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome EvaluationRecruitingNCT06649201
- Dapagliflozin in Allo-HCT for aGVHDRecruitingNCT06626737Phase 2
- A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)RecruitingNCT06619561Phase 2
- A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)RecruitingNCT06615050Phase 3
- A Clinical Study of Bacillus Coagulans in Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell TransplantationNot yet recruitingNCT06593834Not applicable
- Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHDRecruitingNCT06568328Phase 1
- Low-dose Cyclophosphamide or CNI in the Prevention of Acute Graft-versus-host Disease After gDLINot yet recruitingNCT06490562Not applicable
- Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic DiseasesNot yet recruitingNCT06480630Phase 2
- Combination of Steroid and Humanized CD25 Monoclonal Antibody as First-line Therapy for aGVHDNot yet recruitingNCT06473909Phase 2
- Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.RecruitingNCT06450925Phase 2
- Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune DisordersRecruitingNCT06434363Phase 1/2
- Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCTRecruitingNCT06423131Not applicable
- Validation of Human Drugs Target of Repurposed Drugs and Novel TherapiesNot yet recruitingNCT06412718
- Safety and Efficacy of Treg Cell in the Treatment of GVHDNot yet recruitingNCT06411184Phase 1/2
- Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical XerostomiaRecruitingNCT06392711Phase 1
- Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort StudyNot yet recruitingNCT06386445
- Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCTRecruitingNCT06348602Phase 1/2
- SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence TomographyRecruitingNCT06321003
- Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line TreatmentNot yet recruitingNCT06304025Phase 1/2
- Physical Therapy in Patients Undergoing Allo-HSCT With cGVHDNot yet recruitingNCT06279585Not applicable
- Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft TransplantationRecruitingNCT06252870Phase 2
- Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 BlockadeNot yet recruitingNCT06238245Phase 2
- A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)Enrolling by invitationNCT06186804Phase 2
- Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell DressingRecruitingNCT06149832Phase 4
- Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCTRecruitingNCT06143501
- Steroids Versus ECP and Steroids as First-line Treatment of Grade II Acute GVHDNot yet recruitingNCT06133192Phase 2
- Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell TransplantationRecruitingNCT06008808Phase 1
- Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease ProphylaxisNot yet recruitingNCT06000982Phase 3
- Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host DiseaseNot yet recruitingNCT05969743Phase 2
- Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHDRecruitingNCT05921305Phase 3
- Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant RecipientsRecruitingNCT05866302
- Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)RecruitingNCT05692713
- A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell TransplantRecruitingNCT05675930Phase 2
- CD34+ Enriched Transplants to Treat Myelodysplastic SyndromeNot yet recruitingNCT05617625Not applicable
- Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT ModelRecruitingNCT05599256Phase 2